Gene drive system and method of use thereof
US-2024409959-A1 · Dec 12, 2024 · US
US2017114367A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2017114367-A1 |
| Application number | US-201615066063-A |
| Country | US |
| Kind code | A1 |
| Filing date | Mar 10, 2016 |
| Priority date | Oct 26, 2015 |
| Publication date | Apr 27, 2017 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for bacterial genome editing includes: providing a bacterial cell; transforming a pCas9 plasmid and a pKD46 plasmid into the bacterial cell; co-transforming a pCRISPR::LacZ plasmid and an exogenous DNA into the bacterial cell carrying the pCas9 plasmid and the pKD46 plasmid, so as to obtain a strain broth; and spreading the strain broth on a culture medium to conduct cultivation.
Opening claim text (preview).
What is claimed is: 1 . A method for bacterial genome editing, comprising following steps: providing a bacterial cell; transforming a pCas9 plasmid and a pKD46 plasmid into the bacterial cell; co-transforming a pCRISPR::LacZ plasmid and an exogenous DNA into the bacterial cell carrying the pCas9 plasmid and the pKD46 plasmid, so as to obtain a strain broth; and spreading the strain broth on a culture medium to conduct cultivation. 2 . The method for bacterial genome editing as claimed in claim 1 , wherein after the steps of co-transforming the pCRISPR::LacZ plasmid and the exogenous DNA into the bacterial cell carrying the pCas9 plasmid and the pKD46 plasmid, further comprises following steps: using a Cas9 protein and a guide RNA which can identify a LacZ gene to specifically cut at a specific cutting site of the LacZ gene in the bacterial cell; and inserting the exogenous DNA into the specific cutting site of the LacZ gene in the bacterial cell, and obtaining the strain broth. 3 . The method for bacterial genome editing as claimed in claim 1 , wherein the bacterial cell is an Escherichia coli. 4 . The method for bacterial genome editing as claimed in claim 3 , wherein the Escherichia coli is a bacterial strain of MG1655. 5 . The method for bacterial genome editing as claimed in claim 1 , wherein the guide RNA is expressed from the pCRISPR::LacZ plasmid which can identify the LacZ gene. 6 . The method for bacterial genome editing as claimed in claim 1 , wherein a method of transforming the pCas9 plasmid and the pKD46 plasmid into the bacterial cell is an electroporation method. 7 . The method for bacterial genome editing as claimed in claim 1 , wherein a method of co-transforming the pCRISPR::LacZ plasmid and the exogenous DNA into the bacterial cell carrying the pCas9 plasmid and the pKD46 plasmid is an electroporation method. 8 . The method for bacterial genome editing as claimed in claim 1 , wherein the culture medium contains isopropyl β-D-1-thiogalactopyranoside, 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside, Kanamycin, and Tetracycline. 9 . The method for bacterial genome editing as claimed in claim 1 , wherein a cultivation condition of the strain broth is at 37° C. for 16 to 24 hours. 10 . A method for bacterial genome editing, comprising following steps: providing a bacterial cell; co-transforming a pHR_trc template plasmid and a pCas9-NSI plasmid into the bacterial cell to obtain a strain broth; and spreading the strain broth on a culture medium to conduct cultivation. 11 . The method for bacterial genome editing as claimed in claim 10 , wherein the bacterial cell is a cyanobacteria. 12 . The method for bacterial genome editing as claimed in claim 11 , wherein the cyanobacteria is a bacterial strain of S. elongatus PCC7942. 13 . The method for bacterial genome editing as claimed in claim 10 , wherein the pHR_trc template plasmid is used as a homologous recombination template. 14 . The method for bacterial genome editing as claimed in claim 10 , wherein the pHR_trc template plasmid contains a Spectinomycin resistance gene Spec R , a fluorescent protein EGFP, and a homologous recombination region NSIa and NSIb. 15 . The method for bacterial genome editing as claimed in claim 10 , wherein the pCas9-NSI plasmid is used for correctly binding to a predetermined position to conduct a genetic recombination process. 16 . The method for bacterial genome editing as claimed in claim 15 , wherein the predetermined position is a double-strand break locus. 17 . The method for bacterial genome editing as claimed in claim 10 , wherein a method of co-transforming the pHR_trc template plasmid and the pCas9-NSI plasmid into the bacterial cell is phagocytosis. 18 . The method for bacterial genome editing as claimed in claim 10 , wherein the culture medium is a BG-11 culture medium containing Spectinomycin.
Expression systems using regulatory sequences derived from the lac-operon · CPC title
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora · CPC title
using homologous recombination · CPC title
for bacteria · CPC title
Vectors or expression systems specially adapted for E. coli · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.